Integrated Quantitative Investments LLC Takes $812,000 Position in Genpact Limited (NYSE:G)

Integrated Quantitative Investments LLC purchased a new position in shares of Genpact Limited (NYSE:GFree Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 18,900 shares of the business services provider’s stock, valued at approximately $812,000.

Several other large investors also recently bought and sold shares of the business. SRH Advisors LLC purchased a new stake in Genpact in the 4th quarter valued at $26,000. Atlas Capital Advisors Inc. boosted its position in shares of Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock valued at $26,000 after acquiring an additional 216 shares during the last quarter. Manchester Capital Management LLC purchased a new stake in shares of Genpact in the fourth quarter valued at about $38,000. Smartleaf Asset Management LLC increased its position in Genpact by 416.5% during the fourth quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider’s stock worth $41,000 after purchasing an additional 783 shares during the last quarter. Finally, UMB Bank n.a. raised its stake in Genpact by 55.7% during the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider’s stock worth $52,000 after purchasing an additional 433 shares during the period. Hedge funds and other institutional investors own 96.03% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently weighed in on the stock. Mizuho increased their price target on shares of Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. Needham & Company LLC increased their price objective on Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. Jefferies Financial Group raised Genpact from a “hold” rating to a “buy” rating and raised their target price for the stock from $44.00 to $55.00 in a research note on Tuesday, January 21st. Finally, TD Cowen raised Genpact from a “hold” rating to a “buy” rating and upped their price target for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Six equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $48.44.

View Our Latest Report on G

Genpact Price Performance

G stock opened at $47.08 on Friday. The business’s fifty day moving average price is $51.20 and its 200 day moving average price is $45.39. Genpact Limited has a 12-month low of $30.23 and a 12-month high of $56.76. The company has a market capitalization of $8.27 billion, a PE ratio of 16.58, a P/E/G ratio of 1.84 and a beta of 1.06. The company has a current ratio of 2.16, a quick ratio of 1.85 and a debt-to-equity ratio of 0.50.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings results on Thursday, February 6th. The business services provider reported $0.82 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. On average, sell-side analysts anticipate that Genpact Limited will post 3.21 EPS for the current year.

Genpact Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were paid a $0.17 dividend. This is an increase from Genpact’s previous quarterly dividend of $0.15. The ex-dividend date of this dividend was Tuesday, March 11th. This represents a $0.68 annualized dividend and a dividend yield of 1.44%. Genpact’s payout ratio is 23.94%.

Insider Activity

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the stock in a transaction that occurred on Thursday, March 13th. The shares were sold at an average price of $48.89, for a total value of $664,904.00. Following the sale, the chief executive officer now directly owns 310,246 shares of the company’s stock, valued at approximately $15,167,926.94. This represents a 4.20 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Piyush Mehta sold 12,000 shares of the business’s stock in a transaction on Friday, January 10th. The stock was sold at an average price of $42.83, for a total transaction of $513,960.00. Following the transaction, the senior vice president now owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The disclosure for this sale can be found here. Insiders own 2.80% of the company’s stock.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Read More

Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:GFree Report).

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.